The question is not simply "does the patient have enough kidney failure to be transplanted?" The real question is: "can this patient receive a kidney transplant with acceptable risk and obtain a meaningful clinical benefit?"
The pretransplant evaluation seeks to understand the patient's overall condition, identify diseases that may increase perioperative or later risk, and correct, whenever possible, conditions that could compromise the outcome.
The recipient should reach transplant with a reasonably good prognosis and a real chance of improving survival and quality of life.
A potential recipient cannot be evaluated from the kidney perspective alone. The assessment must integrate at least:
The ultimate goal is to identify risks before administering immunosuppression and performing major surgery.
The evaluation begins with a complete medical history.
Kidney diseaseWe need to know:
The disease that caused kidney failure also matters because some conditions can recur in the graft.
ComorbiditiesAsk specifically about:
Previous surgeries, regular medications, allergies, and anesthetic history should also be reviewed.
This is one of the most important components of the pretransplant workup. Patients with CKD have a high burden of cardiovascular risk factors, including diabetes, hypertension, dyslipidemia, obesity, smoking, and abnormalities related to uremia itself.
Cardiovascular disease is a leading cause of morbidity and mortality after transplant, which is why its preoperative evaluation is emphasized.
Initial evaluationIt should include:
Not all patients need exactly the same tests. The depth of the evaluation should be adjusted to the individual cardiovascular risk.
Factors that raise concernWhen the initial evaluation identifies significant risk, additional cardiology studies may be necessary, including functional ischemia testing and, in selected patients, invasive coronary evaluation.
Key concept
The goal is not to order a coronary angiogram for every recipient, but to identify which patient needs a deeper cardiovascular evaluation.
Vascular disease has two different implications. First, it is a marker of systemic atherosclerotic disease and higher cardiovascular risk. Second, it can become a technical problem for kidney implantation.
Severe aortoiliac atheromatosis can make the vascular anastomoses difficult to perform. In symptomatic patients, or those with suspected significant vascular disease, the workup should be extended with vascular imaging.
Vascular anatomy and the specific planning of the iliac fossa where the kidney will be implanted will be covered in Lesson 3 · Urological and surgical evaluation of the recipient.
This point is critical because the patient will receive immunosuppression after transplant. An infection of little relevance in an immunocompetent patient can become considerably severe after transplant.
That is why we must look for:
Active infectionsA significant active infection must be identified and treated before transplant when appropriate.
Latent infectionsSome infections can remain controlled for years and later reactivate because of immunosuppression.
SerologiesThe pretransplant workup should establish the recipient's infectious status for various agents relevant to later patient management. Of particular importance among them:
Viral hepatitis must be evaluated before starting immunosuppression because of the risk of reactivation and later complications.
VaccinationWhenever possible, the vaccination schedule should be optimized before transplant. This is especially important because certain vaccines may later be contraindicated or may produce a weaker immune response under immunosuppression.
Alert
Significant active infection + immunosuppression = potentially dangerous combination. Transplant may need to be deferred until the infection is controlled.
Immunosuppression changes the cancer risk of the transplant recipient. That is why we need to know:
In addition, the cancer screening appropriate for age, sex, and risk factors must be completed.
The presence of an active malignancy may modify or defer the indication for transplant. But a history of cancer does not automatically mean the patient can never be transplanted. The decision depends on tumor type, stage, treatment, risk of recurrence, and the individual clinical situation.
Key concept
We should not think "previous cancer = definitive contraindication." We should think "what is the oncological risk of immunosuppressing this patient?"
Diabetes is especially important because it can simultaneously be a cause of CKD, a cardiovascular risk factor, an infectious risk factor, and a surgical risk factor. Metabolic control and the presence of associated vascular damage must be evaluated.
Obesity can also increase surgical complexity, wound complications, cardiovascular risk, and later metabolic risk.
The evaluation should individualize risk and aim to optimize modifiable conditions before surgery.
Liver disease can substantially change the risk of transplant. We must consider:
Viral liver disease must be adequately characterized before immunosuppression is given. In selected cases, it may be necessary to discuss combined transplant strategies or other alternatives.
Chronological age alone does not fully describe a patient's risk. Two people of the same age can have completely different functional capacities. That is why we must assess:
Key concept
We evaluate the patient, not just the date of birth.
Kidney transplantation demands a long-term therapeutic commitment. After surgery, the recipient must take immunosuppressants daily, attend follow-up visits, undergo laboratory tests, recognize warning signs, follow preventive measures, and stay in follow-up for years.
That is why we must assess:
Psychosocial aspects are part of the overall evaluation and may require the involvement of psychology, psychiatry, or social work.
Not every situation that prevents transplant today means the patient will never be able to receive one. It is more useful to think in terms of three scenarios:
🟢 Suitable candidate
The expected benefit reasonably outweighs the risks, and there are no major pending problems.
🟡 Potentially suitable candidate, but needs optimization
For example: an infection that must be treated, a pending cardiovascular evaluation, obesity or malnutrition requiring intervention, an incomplete oncological workup, a potentially correctable adherence problem, or the need to first resolve a particular condition. Once the situation is resolved, the patient can be reevaluated.
🔴 Currently unacceptable risk
There is a condition that makes the risk of transplant and immunosuppression clearly outweigh the expected benefit at that time.
Clinical pearl
"Not suitable today" does not necessarily mean "not suitable forever."
Kidney transplantation is essentially multidisciplinary. The decision may involve:
The goal is not to find a patient with "no risk". Such a patient practically does not exist. The goal is to determine whether the risk is acceptable, modifiable, and proportional to the expected benefit.
PDF pending upload.
Patient with advanced CKD, potential transplant candidate:
Is there any condition that significantly increases risk?
🟢 No
Potentially suitable candidate.
🟡 Yes, but it is correctable
Treat / optimize → reevaluate.
🔴 Yes, and the current risk is unacceptable
Defer / do not currently indicate → reconsider based on course.
Clinical pearl for residents
The pretransplant evaluation is not about finding the perfect patient. It aims to identify what risks the patient has, which ones we can modify, and whether the benefit of transplant justifies moving forward.
What is one of the main goals of the pretransplant evaluation?
Correct: B.
Which area deserves special attention because of its impact on morbidity and mortality?
Correct: A.
A significant active infection before transplant:
Correct: B.
A history of cancer means the patient can never be transplanted:
Correct: B.
Should adherence be evaluated before transplant?
Correct: A.
A patient who is initially unsuitable can later become a candidate:
Correct: A.